Abstract. To 
p<0.005) during treatment, whereas serum levels of calcidiol, and calcium remained unchanged. The serum level of procollagen type I C-terminal propeptide rose 15% (7- (8) . Hyaluronan is a high molecular weight polysaccharide which is particularly abun¬ dant in soft connective tissue where it is thought to be of importance in the regulation of interstitial fluid volume (9) . Hyaluronan is transported from the tissues via the lymphatic system to the general circulation where increased levels have been ob¬ served in various fibrosing conditions (10, 11) .
The present study was undertaken in order to investigate the in vivo effect of short-term calcitriol administration to healthy male volunteers on bone and soft connective tissue metabolism as estimated by seromarkers of extracellular matrix components and osteoblast activity.
Subjects and Methods
Fifteen male volunteers aged 28- (12) . The volunteers were on normal diel and without restriction of physical activity. Data on calcium and non-collagen bone metabolism for 7 of the partici¬ pants have been published previously (13) . PICP (11, 17) . Inter-as¬ say cv was 8.3%. Serum osteocalcin (bone gla protein) was measured by RIA (18) . Intra-and inter-assay cv were 5 and 10%, respectively. Alkaline phosphatase activity in serum was measured spectrophotometrically as recom¬ mended by the Scandinavian Committee on Enzymes (19) . Intra-and inter-assay cv were 2.5 and 5%, respec¬ tively. Serum calcidiol and calcitriol were determined by competitive protein binding assays. The intra-and interassay variations were 9.1 and 13.5% for calcidiol, and 1 1 and 11% for calcitriol (12, 20 Osteocalcin is the most abundant non-collagen organic constituent of bone, and is solely produced by osteoblasts (21) . Serum osteocalcin mainly re¬ flects newly synthesized protein (21, 22) and corre¬ lates with bone formation at organ and tissue level (23) . However, osteocalcin release to serum may be rapidly regulated by several factors (24, 25) and such changes may occur independently of bone formation. Calcitriol stimulates the production of osteocalcin in vitro (4) . The augmentation of serum osteocalcin under the present experimental condi¬ tions ( Fig. 1) accords with previous observations in healthy control subjects (13, 26) and osteoporotic postmenopausal women (26 
